Isothermal titration calorimetry: Controlling binding forces in lead optimization

Drug Discovery Today: Technologies

Volumn 1, Issue 3, 2004, Pages 295-299

  Freire, Ernesto ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE INHIBITOR; SAQUINAVIR; TMC 126; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; DRUG BINDING; DRUG RESEARCH; ENTHALPY; ENTROPY; HUMAN; HYDROGEN BOND; INTERMETHOD COMPARISON; ISOTHERMAL TITRATION CALORIMETRY; LIPOPHILICITY; MEDICAL TECHNOLOGY; PROTON TRANSPORT; THERMODYNAMICS;

EID: 13344284025     PISSN: 17406749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ddtec.2004.11.016     Document Type: Review

References (12)

1. C.A. Lipinski et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings Adv. Drug Deliv. Rev. 23 1997 3-25
2. C.A. Lipinski Drug-like properties and the causes of poor solubility and poor permeability J. Pharmacol. Toxicol. Methods 44 2000 235-249
3. Lipinski, C.A. (2003) Physicochemical properties and the discovery of orally active drugs: Technical and people issues. In Molecular Informatics Confronting Complexity. Proceedings of the Beilstein Institute Workshop, 13th-16th May 2002 (Kettner, M.G.Ha.C., ed.), pp. 59-78, Logos Verlag
4. T. Wiseman et al. Rapid measurement of binding constants and heats of binding using a new titration calorimeter Anal. Biochem. 179 1989 131-135
5. S. Leavitt E. Freire Direct measurement of protein binding energetics by isothermal titration calorimetry Curr. Opin. Struct. Biol. 11 2001 560-566
6. P.C. Weber F.R. Salemme Applications of calorimetric methods to drug discovery and the study of protein interactions Curr. Opin. Struct. Biol. 13 2003 115-121
7. A. Velazquez-Campoy et al. Characterization of protein-protein interactions by isothermal titration calorimetry Methods Mol. Biol. 261 2004 35-54
8. M.J. Todd et al. The thermodynamic basis of resistance to HIV-1 protease inhibition mutant Biochemistry 39 2000 11876-11883
9. A. Velazquez-Campoy et al. The binding energetics of first and second generation HIV-1 protease inhibitors: Implications for drug design Arch. Biochim. Biophys. 390 2001 169-175
10. S. Cabani et al. Group contributions to the thermodynamic properties of non-ionic organic solutes in dilute aqueous solution J. Solution Chem. 10 1981 563-595
11. A. Velazquez-Campoy et al. Structural and thermodynamic basis of resistance to HIV-1 protease inhibition: Implications for inhibitor design Curr. Drug Targets Infect. Disord. 3 2003 311-328
12. H. Ohtaka et al. Thermodynamic rules for the design of high affinity HIV-1 protease inhibitors with adaptability to mutations and high selectivity towards unwanted targets Int. J. Biochem. Cell Biol. 36 2004 1787-1799